ym 09151-2 has been researched along with Brain Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, LP; Waszczak, BL; Zahr, NM | 1 |
| Araki, T; Itoyama, Y; Kato, H; Tanji, H | 1 |
2 other study(ies) available for ym 09151-2 and Brain Disorders
| Article | Year |
|---|---|
Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
Topics: Action Potentials; Animals; Apomorphine; Basal Ganglia; Benzamides; Benzazepines; Brain Diseases; Brain Mapping; Cell Count; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Male; Neurons; Rats; Rats, Sprague-Dawley; Subthalamic Nucleus | 2004 |
Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
Topics: Adrenergic Agents; Animals; Autoradiography; Benzamides; Benzazepines; Brain Diseases; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Male; Mazindol; Medial Forebrain Bundle; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Factors | 1998 |